GRAM.OTC.PinkGold Flora CORP

10-K: Gold Flora Corporation Reports Full Year 2023 Results Following Merger with TPCO

Sentiment:

Annual Results


Gold Flora Corporation released its full year 2023 results, highlighting the impact of its merger with TPCO and strategic restructuring efforts.

Capital raiseThe company plans to raise additional capital as needed which if not available as required would raise substantial doubt about our ability to continue as a going concern.The company expects to have access to public capital markets through its listing on the Cboe Canada exchange if the trading price of its Common Stock improves, and will continue to review and pursue selected external financing sources to ensure adequate financial resources.
Worse than expectedThe company's net loss increased significantly year-over-year, indicating worse than expected financial performance.The company's adjusted EBITDA decreased significantly year-over-year, indicating worse than expected operational performance.

Summary

  • Gold Flora Corporation, a vertically integrated cannabis company in California, reported its full year 2023 results, which include the impact of its merger with TPCO Holding Corp. on July 7, 2023.
  • The company operates in three segments: retail, wholesale, and management, with 16 dispensaries in California and plans to open a 17th by June 2024.
  • Gold Flora's cultivation operations include 107,000 square feet of indoor canopy across multiple campuses, with an additional 240,000 square feet of expansion potential at its Desert Hot Springs campus.
  • The company's manufacturing arm, Black Lion Labs, operates a 10,000 square foot facility, and its distribution network, Stately Distribution, has three core hubs in California.
  • The merger with TPCO resulted in a significant increase in revenue, with total net revenues reaching $90.96 million for 2023, compared to $65.66 million in 2022.
  • The company reported a net loss of $42.66 million for 2023, compared to a net loss of $21.52 million in 2022, which includes non-recurring transaction costs and impairment charges.
  • The company has implemented cost-cutting initiatives, including reductions in marketing, professional services, and personnel expenses, and has nearly eliminated its reliance on third-party vendors for biomass, manufacturing, and distribution.
  • The company estimates annual flower production to be over 40,000 lbs when all flower rooms are operating optimally.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While there are positive developments such as revenue growth and strategic initiatives, the significant net loss, material weakness in internal controls, and the need for additional capital raise concerns. The overall sentiment is cautiously negative.

Positives

  • The merger with TPCO has significantly increased the company's scale and market presence.
  • The company has successfully integrated its operations and reduced its reliance on third-party vendors.
  • The company has launched new product brands and expanded its distribution network.
  • The company has implemented cost-cutting measures that have resulted in substantial annualized cost savings.
  • The company has increased its cultivation capacity and is estimated to produce over 40,000 lbs of flower annually.

Negatives

  • The company reported a net loss of $42.66 million for 2023, compared to a net loss of $21.52 million in 2022.
  • The company incurred significant non-recurring transaction costs and impairment charges related to the merger.
  • The company has identified a material weakness in its internal control over financial reporting.
  • The company is subject to the risks associated with operating in the cannabis industry, including regulatory uncertainty and competition from the illegal market.

Risks

  • The company is subject to the risks associated with operating in the cannabis industry, including regulatory uncertainty and competition from the illegal market.
  • The company may have difficulty accessing the services of banks, which may make it difficult to operate its business.
  • The company may have difficulty accessing public and private capital.
  • The company is subject to the risks associated with governmental approvals, permits and compliance with applicable laws.
  • The company may be subject to product liability claims.
  • The company may be subject to risks related to information technology systems, including cyberattacks.
  • The company may not realize the anticipated synergies, cost savings or profits from acquisitions.
  • The company may be subject to the risk of litigation.
  • The company may be required to take further write-downs or write-offs, restructuring and impairment or other charges that could have a significant negative effect on our financial condition, results of operations and Common Stock price, which could cause investors to lose some or all of their investment.

Future Outlook

The company plans to continue to evaluate and implement additional cost reductions and business optimization to reduce cash burn, accelerate market share growth, improve gross and operating margin profile and progress quickly to generating sustained free cash flow.

Management Comments

  • The company is focused on building a strong base from which it can deliver returns to shareholders.
  • The company is known for its transparency in production and compliance with the highest standards in the industry.
  • The company is using its data infrastructure proactively to track, monitor and reconcile inventory levels and for ongoing reconciliation with METRC.

Industry Context

The announcement reflects the ongoing consolidation and growth within the California cannabis market, with companies seeking to achieve scale and efficiency through vertical integration and strategic acquisitions. The company is also navigating the challenges of operating in a highly regulated and competitive industry, including the presence of a significant illegal market.

Comparison to Industry Standards

  • The company's revenue growth of 38.5% year-over-year is above the average growth rate for the cannabis industry in California, which has seen a decline in average price per pound of cannabis biomass throughout 2022.
  • The company's vertical integration strategy is similar to other large cannabis operators in California, such as Curaleaf and Trulieve, which aim to control the entire supply chain from cultivation to retail.
  • The company's focus on cost-cutting and operational efficiencies is in line with industry trends, as companies seek to improve profitability in a challenging market.
  • The company's expansion of its distribution network is similar to other large cannabis operators in California, such as Nabis and HERBL, which aim to provide a wide range of products to dispensaries across the state.
  • The company's launch of new product brands is similar to other large cannabis operators in California, such as Cookies and Lowell Herb Co., which aim to differentiate themselves in a competitive market.

Related Party Transactions

  • The company has various transactions with related parties, including facility rent, construction of facilities, shared services, and interest expense.

Stakeholder Impact

  • Shareholders may be concerned about the company's net loss and the material weakness in internal controls.
  • Employees may be affected by the company's cost-cutting measures.
  • Customers may benefit from the company's expanded product offerings and retail locations.
  • Suppliers may be affected by the company's efforts to reduce its reliance on third-party vendors.
  • Creditors may be concerned about the company's ability to repay its debts.

Next Steps

  • The company plans to continue to evaluate and implement additional cost reductions and business optimization.
  • The company plans to integrate its back-office infrastructure and has identified other synergies and cost-saving initiatives.
  • The company plans to launch the Gramlin product brand in the first quarter of 2024.
  • The company anticipates opening a 17th dispensary in Costa Mesa before the end of June 2024.

Key Dates

DateDescription
July 7, 2023Gold Flora Corporation consummated its business combination with TPCO Holding Corp.
June 2024Anticipated opening of the 17th dispensary in Costa Mesa.

Keywords

cannabis, merger, TPCO, cultivation, distribution, retail, manufacturing, California, financial results, cost savings

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.